Maria Asuncion Espinosa, Amy Lack, Daniel Kenney, Luis G Arroyo
{"title":"Retrospective assessment of equine herpesvirus type 1 (EHV-1) genotype-associated clinical disease in Ontario.","authors":"Maria Asuncion Espinosa, Amy Lack, Daniel Kenney, Luis G Arroyo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Equine herpesvirus type 1 (EHV-1) is an important viral pathogen in horses, associated with diverse clinical manifestations including fever, upper and lower respiratory disease, neurological signs, ocular disease, and abortion. Currently, EHV-1 variants (genotypes) are classified based on a single nucleotide polymorphism mutation of the open reading frame 30 (ORF30).</p><p><strong>Objective animals and procedure: </strong>The aim of this retrospective study was to evaluate the EHV-1 genotypes present in horses with various clinical presentations, including respiratory disease, abortion, and neurological disease, at a referral center in the province of Ontario.</p><p><strong>Results: </strong>Equine herpesvirus type 1 was detected in 11.7% of the tested horses, with clinical presentations including abortion (21%), myeloencephalopathy (64%), fever (11%), pneumonia (3.5%), and asymptomatic cases (3.5%). The neuropathogenic strain was more commonly present in horses with abortions and fevers. Equine herpesvirus myeloencephalopathy was associated with the non-neuropathogenic strain in 50% of the cases and the neuropathogenic strain in 44% of the cases. However, in 6% of the cases, the viral genotype was unknown.</p><p><strong>Conclusion and clinical relevance: </strong>These findings highlighted that this is a multifactorial problem and clinical disease may not be solely attributed to viral genome. This variability reinforced the need for continued research into the behavior and epidemiology of EHV-1.</p>","PeriodicalId":9429,"journal":{"name":"Canadian Veterinary Journal-revue Veterinaire Canadienne","volume":"67 5","pages":"499-503"},"PeriodicalIF":1.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13142071/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Veterinary Journal-revue Veterinaire Canadienne","FirstCategoryId":"97","ListUrlMain":"","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Equine herpesvirus type 1 (EHV-1) is an important viral pathogen in horses, associated with diverse clinical manifestations including fever, upper and lower respiratory disease, neurological signs, ocular disease, and abortion. Currently, EHV-1 variants (genotypes) are classified based on a single nucleotide polymorphism mutation of the open reading frame 30 (ORF30).
Objective animals and procedure: The aim of this retrospective study was to evaluate the EHV-1 genotypes present in horses with various clinical presentations, including respiratory disease, abortion, and neurological disease, at a referral center in the province of Ontario.
Results: Equine herpesvirus type 1 was detected in 11.7% of the tested horses, with clinical presentations including abortion (21%), myeloencephalopathy (64%), fever (11%), pneumonia (3.5%), and asymptomatic cases (3.5%). The neuropathogenic strain was more commonly present in horses with abortions and fevers. Equine herpesvirus myeloencephalopathy was associated with the non-neuropathogenic strain in 50% of the cases and the neuropathogenic strain in 44% of the cases. However, in 6% of the cases, the viral genotype was unknown.
Conclusion and clinical relevance: These findings highlighted that this is a multifactorial problem and clinical disease may not be solely attributed to viral genome. This variability reinforced the need for continued research into the behavior and epidemiology of EHV-1.
期刊介绍:
The Canadian Veterinary Journal (CVJ) provides a forum for the discussion of all matters relevant to the veterinary profession. The mission of the Journal is to educate by informing readers of progress in clinical veterinary medicine, clinical veterinary research, and related fields of endeavor. The key objective of The CVJ is to promote the art and science of veterinary medicine and the betterment of animal health.
A report suggesting that animals have been unnecessarily subjected to adverse, stressful, or harsh conditions or treatments will not be processed for publication. Experimental studies using animals will only be considered for publication if the studies have been approved by an institutional animal care committee, or equivalent, and the guidelines of the Canadian Council on Animal Care, or equivalent, have been followed by the author(s).